SIENTRA, INC. (NASDAQ:SIEN) Files An 8-K Results of Operations and Financial ConditionItem 2.02.
| Item 2.02. | Financial Statements and Exhibits. |
|
ExhibitNo. |
Description |
| 99.1 | Earnings Press release of Sientra, Inc. dated August9, 2017. |
Sientra, Inc. ExhibitEX-99.1 2 d438454dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Sientra® Reports Second Quarter 2017 Financial Results Remains on Track for FDA PMA Supplement Approval by End of 2017 Completed Acquisition of Miramar Labs,…To view the full exhibit click here
About SIENTRA, INC. (NASDAQ:SIEN)
Sientra, Inc. is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. The Company’s breast implants incorporate one or more differentiated technologies, including a cohesive silicone gel and texturing branded TRUE Texture. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth.
